LT99016A - 2-fenil-1,2-benzizoselenazol-3(2h)-ono panaudojimas alchaimerio ligos gydymui skirtai farmacinei kompozicijai gauti - Google Patents

2-fenil-1,2-benzizoselenazol-3(2h)-ono panaudojimas alchaimerio ligos gydymui skirtai farmacinei kompozicijai gauti

Info

Publication number
LT99016A
LT99016A LT99-016A LT99016A LT99016A LT 99016 A LT99016 A LT 99016A LT 99016 A LT99016 A LT 99016A LT 99016 A LT99016 A LT 99016A
Authority
LT
Lithuania
Prior art keywords
alzheimer
phenyl
treatment
benzisoselenazol
disease
Prior art date
Application number
LT99-016A
Other languages
English (en)
Other versions
LT4602B (lt
Inventor
Ikuro Maruyama
Kazuhiro Abeyama
Hiroyuki Masayasu
Original Assignee
A. Nattermann & Cie. Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A. Nattermann & Cie. Gmbh filed Critical A. Nattermann & Cie. Gmbh
Publication of LT99016A publication Critical patent/LT99016A/lt
Publication of LT4602B publication Critical patent/LT4602B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
LT99-016A 1996-08-27 1999-02-23 2-fenil-1,2-benzizoselenazol-3(2h)-ono panaudojimas alchaimerio ligos gydymui skirtai farmacinei kompozicijai gauti LT4602B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27

Publications (2)

Publication Number Publication Date
LT99016A true LT99016A (lt) 1999-10-25
LT4602B LT4602B (lt) 2000-01-25

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
LT99-016A LT4602B (lt) 1996-08-27 1999-02-23 2-fenil-1,2-benzizoselenazol-3(2h)-ono panaudojimas alchaimerio ligos gydymui skirtai farmacinei kompozicijai gauti

Country Status (28)

Country Link
US (1) US5948800A (lt)
EP (1) EP0826370B1 (lt)
KR (1) KR20000035859A (lt)
CN (1) CN1112922C (lt)
AT (1) ATE219361T1 (lt)
AU (2) AU3866997A (lt)
BR (1) BR9711259A (lt)
CA (1) CA2213794C (lt)
CZ (1) CZ295364B6 (lt)
DE (2) DE59707550D1 (lt)
DK (1) DK0826370T3 (lt)
EE (1) EE03953B1 (lt)
ES (1) ES2177849T3 (lt)
FI (1) FI119622B (lt)
HU (1) HU225264B1 (lt)
IL (1) IL127113A (lt)
LT (1) LT4602B (lt)
LV (1) LV12251B (lt)
NO (1) NO312812B1 (lt)
NZ (1) NZ332292A (lt)
PL (1) PL188481B1 (lt)
PT (1) PT826370E (lt)
SI (1) SI9720060B (lt)
TR (1) TR199700858A2 (lt)
TW (1) TW501925B (lt)
UA (1) UA59367C2 (lt)
WO (2) WO1998008511A1 (lt)
ZA (1) ZA977644B (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2145065T3 (es) * 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
HU225264B1 (en) 2006-08-28
UA59367C2 (uk) 2003-09-15
NO973912D0 (no) 1997-08-26
AU3866997A (en) 1998-03-19
IL127113A (en) 2003-07-06
CN1223580A (zh) 1999-07-21
WO1998008511A1 (de) 1998-03-05
TR199700858A2 (xx) 1998-03-21
PL188481B1 (pl) 2005-02-28
NO973912L (no) 1998-03-02
CA2213794C (en) 2006-10-03
LV12251B (lv) 1999-08-20
PL321796A1 (en) 1998-03-02
SI9720060B (en) 2001-12-31
BR9711259A (pt) 1999-08-17
FI119622B (fi) 2009-01-30
EE9900007A (et) 1999-06-15
NZ332292A (en) 2001-07-27
EE03953B1 (et) 2003-02-17
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
CA2213794A1 (en) 1998-02-27
CZ295364B6 (cs) 2005-07-13
FI982689L (fi) 1998-12-11
LV12251A (lv) 1999-04-20
ATE219361T1 (de) 2002-07-15
US5948800A (en) 1999-09-07
EP0826370B1 (de) 2002-06-19
KR20000035859A (ko) 2000-06-26
DE59707550D1 (de) 2002-07-25
FI982689A0 (fi) 1998-12-11
ZA977644B (en) 1999-02-26
HK1020317A1 (en) 2000-04-14
LT4602B (lt) 2000-01-25
TW501925B (en) 2002-09-11
HUP9903213A1 (en) 2000-07-28
CZ31799A3 (cs) 1999-11-17
HUP9903213A3 (en) 2000-12-28
SI9720060A (sl) 1999-06-30
AU725534B2 (en) 2000-10-12
NO312812B1 (no) 2002-07-08
AU3529897A (en) 1998-03-05
CN1112922C (zh) 2003-07-02
ES2177849T3 (es) 2002-12-16
EP0826370A1 (de) 1998-03-04
IL127113A0 (en) 1999-09-22
WO1998008831A1 (en) 1998-03-05
PT826370E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
LT99016A (lt) 2-fenil-1,2-benzizoselenazol-3(2h)-ono panaudojimas alchaimerio ligos gydymui skirtai farmacinei kompozicijai gauti
CA2191101A1 (en) Materials and methods for treatment of plaquing diseases
CA2264097A1 (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
EG19730A (en) Method of preparing and use of magnesium-pyridoxal-5-phosphate-glutaminate for the prevention of diseases which result from vascular lesions
AU4759390A (en) Method of medical treatment of alzheimer's disease
GR3026120T3 (en) Use of NADH and NADPH for the manufacture of a medicament for the treatment of Alzheimer's disease
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
CA2078700A1 (en) Imidazolylmethyl-pyridines
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ZA915462B (en) Composition for the treatment of alzheimer's disease and process for preparing the same
AU636488C (en) Use of a 1-2(-naphthylethyl)-4-(3-trifluoromethylphenyl)-1, 2,3,6-tetrahydropyridine for the treatment of cerebral and n euronal diseases
AU2002318888A1 (en) Metal Chelators for use in the treatment of Alzheimer's Disease

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20050407